EUVIMEDSkopri EUVIMED
Studienprotokoll

Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service

Kevin M Krcmarik iD, Benjamin J Hulley, Jiayi Huang, Derek Juang, Peter Cadman, Charisma Urbiztondo, Christine Vo, Jaclyn Vargas, Ramin Motarjemi, Tarlan Moinizandi, Brian Kwan

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023

DOI: 10.1002/phar.2855 ↗

At a glance

Studienprotokoll in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023. Written by Kevin M Krcmarik and 10 co-authors. Institution: Department of Internal Medicine, Section of Hospitalist Medicine, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA. Major MEDLINE topics: Substance Withdrawal Syndrome, Alcoholism, Alcohol Withdrawal Delirium. Cited 3 times so far (Crossref); 31 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objective

To determine if a novel symptom‐based alcohol withdrawal syndrome (AWS) protocol in a US Veterans cohort leads to significant clinical improvements in patient outcomes and safety.

Background

Prior studies of AWS management, oftentimes using the revised version of the Clinical Institute Withdrawal Assessment for Alcohol (CIWA‐Ar) index, have demonstrated the effectiveness of symptom‐triggered therapy for AWS. The Minnesota Detoxification Scale (MINDS) is an alternative to the CIWA‐Ar index but remains unevaluated outside of the intensive care unit (ICU) setting. This study assesses outcomes in AWS management prior to and after the implementation of a novel MINDS‐based AWS protocol (SDAWP) utilizing a revised MINDS index (MINDS‐rev) in an inpatient medical ward setting.

Methods

Retrospective cohort study including encounters prior to ( n = 342) and after ( n = 338) the implementation of the protocol. Pre‐ and post‐protocol encounters were selected by combinations of diagnostic codes and charting elements. Outcome measures of AWS management were obtained in both groups. The primary endpoint was median total benzodiazepine exposure. Secondary outcomes included median length of hospitalization, median duration of benzodiazepine administration, and the incidence of complications.

Results

The median total benzodiazepine exposure in the post‐SDAWP group was significantly lower than the pre‐SDAWP group (21.2 vs. 12.0 mg, p < 0.0001) and for a significantly shorter median duration of time (4.0 vs. 3.0 days, p < 0.0001). There was no significant difference in the median length of stay (4.0 vs. 4.0 days, p = 0.50). The incidence of delirium tremens (21 vs. 7, p = 0.01) and need for transfer to a higher level of care (33 vs. 12, p = 0.002) was significantly lower in the post‐SDAWP group.

Conclusion

The SDAWP has provided significant improvements in AWS management in our institution and may potentially serve as a template for wider use in other inpatient settings.

Subjects

MeSH terms (MEDLINE)

Substance Withdrawal SyndromeAlcoholismAlcohol Withdrawal DeliriumHumansRetrospective StudiesInpatientsMinnesotaBenzodiazepinesEthanol

Author keywords

alcohol withdrawalalcohol withdrawal syndromebenzodiazepineoutcome assessmenttreatment protocol

Substances

BenzodiazepinesEthanol

Authors and institutions

  • Department of Internal Medicine, Section of Hospitalist Medicine, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA.
  • Department of Pharmacy, Jennifer Moreno Veterans Affairs Medical Center, San Diego, California, USA.

ORCID profiles: Kevin M Krcmarik

Cite

APA

Krcmarik, K. M., Hulley, B. J., Huang, J., Juang, D., Cadman, P., Urbiztondo, C., Vo, C., Vargas, J., Motarjemi, R., Moinizandi, T., & Kwan, B. (2023). Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2855

Vancouver

Krcmarik KM, Hulley BJ, Huang J, Juang D, Cadman P, Urbiztondo C, et al. Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023. doi:10.1002/phar.2855

BibTeX
@article{Krcmarik2023,
  author = {Krcmarik, Kevin M and Hulley, Benjamin J and Huang, Jiayi and Juang, Derek and Cadman, Peter and Urbiztondo, Charisma and Vo, Christine and Vargas, Jaclyn and Motarjemi, Ramin and Moinizandi, Tarlan and Kwan, Brian},
  title = {Assessment of a modified MINDS ‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2023},
  doi = {10.1002/phar.2855}
}
Start for free →